Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed
- PMID: 25965444
- PMCID: PMC4444033
- DOI: 10.1155/2015/943410
Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed
Figures
Comment in
-
The Authors respond.Can J Gastroenterol Hepatol. 2015 May;29(4):222. doi: 10.1155/2015/521479. Can J Gastroenterol Hepatol. 2015. PMID: 25965446 Free PMC article. No abstract available.
Comment on
-
Patient preference and willingness to pay for transient elastography versus liver biopsy: A perspective from British Columbia.Can J Gastroenterol Hepatol. 2015 Mar;29(2):72-6. doi: 10.1155/2015/169190. Can J Gastroenterol Hepatol. 2015. PMID: 25803016 Free PMC article.
References
-
- Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines? J Hepatol. 2007;46:528–529. author reply 529–30. - PubMed
-
- Myers RP, Fong A, Shaheen AA. Utilization rates, complications and costs of percutaneous liver biopsy: A population-based study including 4275 biopsies. Liver Int. 2008;28:705–12. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical